Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 94
Filtrar
1.
Vestn Khir Im I I Grek ; 159(4): 56-8, 2000.
Artigo em Russo | MEDLINE | ID: mdl-11011406

RESUMO

Hemorheological indices were studied in 89 patients. In 61 patients the authors have revealed somewhat increased viscosity potential of blood and negligible changes in the aggregation activity of erythrocytes which is thought by the authors to be due to the saved compensatory potentialities of the organism. In 28 patients with the complicated course of the disease the rheological parameters of blood became worse because of the suppressed compensatory potentialities of organism. So, in addition to the adequate transfusion-infusion therapy the complex of treatment must include immunostimulating means (Levamisole, Prodigiozan, Tactivin etc.).


Assuntos
Hemorreologia , Abscesso Hepático Amebiano/cirurgia , Adjuvantes Imunológicos/uso terapêutico , Transfusão de Sangue , Viscosidade Sanguínea , Agregação Eritrocítica , Humanos , Levamisol/uso terapêutico , Abscesso Hepático Amebiano/sangue , Abscesso Hepático Amebiano/terapia , Peptídeos/uso terapêutico , Prodigiozan/uso terapêutico , Extratos do Timo/uso terapêutico
2.
Lik Sprava ; (5): 101-5, 1999 Jul.
Artigo em Russo | MEDLINE | ID: mdl-10822692

RESUMO

Based on findings secured with the aid of instrumental and immunological techniques (electroencephalography, echoencephalography, roentgenoencephalography) a total of 57 patients with sequelae of mild craniocerebral injury were examined. Used in the study as an immunomodulating agent was prodigiosan. The drug was found to improve the bioelectrical activity of the brain, and to increase the amplitude of blood filling as evidenced by neurophysiological investigations. Moreover, prodigiosan makes for reduction of vegetovascular disorders and epileptic seizures, returning the level of neurospecific proteins to normal.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Traumatismos Craniocerebrais/terapia , Prodigiozan/uso terapêutico , Adulto , Encéfalo/fisiopatologia , Terapia Combinada , Traumatismos Craniocerebrais/sangue , Traumatismos Craniocerebrais/diagnóstico , Traumatismos Craniocerebrais/fisiopatologia , Progressão da Doença , Nutrição Enteral , Feminino , Hemodinâmica , Humanos , Masculino , Pessoa de Meia-Idade , Proteínas do Tecido Nervoso/sangue , Indução de Remissão
4.
Vestn Ross Akad Med Nauk ; (5): 36-41, 1996.
Artigo em Russo | MEDLINE | ID: mdl-8924825

RESUMO

The effects of hepatotropic growth factors (HGFs) and phospholipid drugs on the recovery of functions and the regeneration of the rat liver were studied in CC14-induced toxic damage and after partial hepatectomy (PHE). HGFs isolated from the cytoplasmic cells of the regenerating liver, as well as from the liver of the animals given prodigiozan and from the media taken after culturing the explants of the regenerating liver were found to stimulate DNA synthesis and hepatocytic proliferation following PHE and in the cirrhotic liver. Prodigiozan was shown to induce the formation of HGFs not only in the rat liver following PHE, but in the liver of intact animals. It was established that the covalently binding complex of albumin and bilirubin stimulated the synthesis of proteins and DNA in the regenerating liver, but non-covalently binding complex inhibited these processes. When CC14 was administered to the animals, the two complexes enhanced the reparative synthesis of DNA, without changing the level of replicating synthesis, the non-covalently binding complex completely eliminating the single-strand breaks in DNA. Phospholipid agents containing soybean and sunflower phosphatidylcholines increased the synthesis of RNA and albumin, which were decreased due to exposure to CC14 and had the property of stimulating the synthesis of total DNA and considerably enhancing that of mitochondrial DNA.


Assuntos
Antibacterianos/farmacologia , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Hepatectomia , Fator de Crescimento de Hepatócito/farmacologia , Regeneração Hepática/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fosfatidilcolinas/farmacologia , Prodigiozan/farmacologia , Animais , Antibacterianos/uso terapêutico , Tetracloreto de Carbono/toxicidade , Doença Hepática Induzida por Substâncias e Drogas/etiologia , DNA/biossíntese , Helianthus , Fator de Crescimento de Hepatócito/uso terapêutico , Fígado/metabolismo , Fígado/fisiologia , Cirrose Hepática Experimental/cirurgia , Fosfatidilcolinas/uso terapêutico , Prodigiozan/uso terapêutico , RNA/biossíntese , Ratos , Glycine max
5.
Eksp Klin Farmakol ; 58(5): 9-12, 1995.
Artigo em Russo | MEDLINE | ID: mdl-8704600

RESUMO

The experiments carried out on mongrel male mice showed that bacterial lipopolysaccharide Prodigiozan inhibit the activity of P-450-dependent monooxygenases of the liver, thus changing the activity of antidepressants--amitriptyline and imipraminum. The data on biological activity were tested in "tail suspension" test. Prodigiozan exhibited no central effect. Changes in biotransformation processes after single administration of both drugs resulted in the delay and prolongation of the effect. Prodigiozan prevents the induction of microsomal enzymes caused by antidepressants. Amitriptyline do not affect the immunostimulating action of prodigiozan, whereas imipraminum inhibited prodigiozan activity.


Assuntos
Adjuvantes Imunológicos/farmacologia , Amitriptilina/farmacologia , Antidepressivos Tricíclicos/farmacologia , Imipramina/farmacologia , Prodigiozan/farmacologia , Adjuvantes Imunológicos/uso terapêutico , Amitriptilina/toxicidade , Animais , Antidepressivos Tricíclicos/toxicidade , Relação Dose-Resposta a Droga , Avaliação Pré-Clínica de Medicamentos , Interações Medicamentosas , Imipramina/toxicidade , Masculino , Camundongos , Prodigiozan/uso terapêutico , Infecções por Pseudomonas/tratamento farmacológico , Infecções por Pseudomonas/mortalidade , Sono/efeitos dos fármacos , Fatores de Tempo
7.
Vestn Otorinolaringol ; (1): 9-11, 1995.
Artigo em Russo | MEDLINE | ID: mdl-7725591

RESUMO

The absolute and relative content of T- and B-lymphocytes, T-helpers (CD4), T-suppressors (CD8), phagocytosis, complement and immunoglobulins A, M, G in the blood serum was examined in patients with chronic purulent otitis media. The investigation also involved tests on immunological activity of tymoptin (T), sodium nucleinate (SN), prodigiosan (PR), the combination of SN with PR. 148 patients aged 15-56 years were subdivided into 5 groups. In pretreatment immunological status of all the patients the count of T- and B-lymphocytes, T-helpers, phagocytosis were reduced against increased counts of IgM and T-suppressora. All the patients received similar conventional treatment with adjuvant SN (group 2), PR (group III), SN + PR (group 4), T (group 5). The conventional conservative and especially surgical treatment aggravated immunodeficiency. The adjuvant immunocorrectors potentiated the treatment effects which appeared to be most beneficial in group V followed by by groups IV, II and III in diminishing order.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Ácidos Nucleicos/uso terapêutico , Otite Média Supurativa/terapia , Prodigiozan/uso terapêutico , Timosina/análogos & derivados , Adolescente , Adulto , Linfócitos B/imunologia , Doença Crônica , Terapia Combinada , Feminino , Humanos , Imunoglobulina A/sangue , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Masculino , Pessoa de Meia-Idade , Otite Média Supurativa/sangue , Otite Média Supurativa/imunologia , Fagócitos/imunologia , Linfócitos T/imunologia , Timosina/uso terapêutico
8.
Radiats Biol Radioecol ; 34(4-5): 582-6, 1994.
Artigo em Russo | MEDLINE | ID: mdl-7951888

RESUMO

It was shown in experiments with mice and dogs that bacterial preparations (vaccinum proteus, prodigiosanum, bificolum and bificolum-f) administered before or after gamma-irradiation have a stimulating effect on hemopoiesis. It is supposed that bacterial polysaccharides play an important role in this action.


Assuntos
Produtos Biológicos/uso terapêutico , Hematopoese/efeitos dos fármacos , Lesões Experimentais por Radiação/terapia , Doença Aguda , Animais , Vacinas Bacterianas/uso terapêutico , Bacteriocinas/uso terapêutico , Cães , Relação Dose-Resposta à Radiação , Camundongos , Prodigiozan/uso terapêutico , Proteus/imunologia , Lesões Experimentais por Radiação/sangue , Fatores de Tempo
9.
Antibiot Khimioter ; 39(2-3): 36-40, 1994.
Artigo em Russo | MEDLINE | ID: mdl-7979793

RESUMO

The diagnostic laparoscopy revealed ascending multifocal affections of the chlamydial origin in the organs of the small pelvis. It provided an objective information on the tuboperitoneal inflammation and made it possible to apply the adequate treatment. The surgical laparoscopy (adhesiotomy and salpingostomy) in the comprehensive treatment with the use of doxycycline and prodigiosan promoted the recovery of the female reproductive function.


Assuntos
Infecções por Chlamydia/tratamento farmacológico , Chlamydia trachomatis , Doxiciclina/uso terapêutico , Infertilidade Feminina/tratamento farmacológico , Peritonite/tratamento farmacológico , Salpingite/tratamento farmacológico , Adulto , Infecções por Chlamydia/complicações , Infecções por Chlamydia/diagnóstico , Doença Crônica , Quimioterapia Combinada , Feminino , Humanos , Infertilidade Feminina/diagnóstico , Infertilidade Feminina/etiologia , Laparoscopia , Peritonite/diagnóstico , Peritonite/etiologia , Prodigiozan/uso terapêutico , Salpingite/diagnóstico , Salpingite/etiologia , Aderências Teciduais
11.
Lik Sprava ; (7): 73-6, 1993 Jul.
Artigo em Russo | MEDLINE | ID: mdl-8209540

RESUMO

64 patients with infectious-allergic bronchial asthma (IABA) were examined. 20 of them were co-administered paspat, 24 patients additionally received prodigiosan, 20 patients constituted control group and were given conventional treatment. Patients of all the groups were comparable in age, state of immunological reactivity of the body and severity of the disease. Immunomodulatory effect of the drugs, mainly of paspat, not only resulted in normalization of functional properties of granulocytes but also promoted liquidation of quantitative and functional IABA-conditioned immunodeficiency on the part of T- and B-lymphocytes, thus increasing effectiveness of the treatment in the whole.


Assuntos
Antígenos de Bactérias/uso terapêutico , Asma/terapia , Prodigiozan/uso terapêutico , Adolescente , Adulto , Asma/imunologia , Avaliação de Medicamentos , Quimioterapia Combinada , Feminino , Humanos , Imunidade Celular/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade
12.
Izv Akad Nauk Ser Biol ; (2): 227-34, 1993.
Artigo em Russo | MEDLINE | ID: mdl-8471974

RESUMO

Radioprotective and therapeutic effects of astazian and astazilide, the drugs of protozoan origin, were studied in comparison with known modifiers of biological reactions (bacterial polysaccharides, synthetic polypeptides) in combined radiation-thermal injuries (CRTI). The efficiency of drugs under examination was found to be time- and dose-dependent. Application of the drugs of protozoan nature 24 hours prior to or 1 hour following CRTI provided 30 to 50% survival of experimental animals for 30 days as compared to 4.5% in the group of untreated mice. Administration of the drugs 3-7 days following CRTI exerted no therapeutic effect.


Assuntos
Queimaduras/prevenção & controle , Eucariotos , Ácidos Graxos/uso terapêutico , Glucanos/uso terapêutico , Polissacarídeos/uso terapêutico , Lesões Experimentais por Radiação/prevenção & controle , Protetores contra Radiação/uso terapêutico , Animais , Queimaduras/tratamento farmacológico , Queimaduras/mortalidade , Avaliação Pré-Clínica de Medicamentos , Lipopolissacarídeos/uso terapêutico , Medições Luminescentes , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Prodigiozan/uso terapêutico , Pirogênios/uso terapêutico , Lesões Experimentais por Radiação/tratamento farmacológico , Lesões Experimentais por Radiação/mortalidade , Fatores de Tempo
14.
Khirurgiia (Mosk) ; (4): 86-90, 1991 Apr.
Artigo em Russo | MEDLINE | ID: mdl-2062077

RESUMO

From experience in the treatment of 326 patients with acute cholecystitis and concomitant obesity the authors discuss the causes of unfavourable outcomes and plan the means for improving the results. Postoperative suppuration of the wound occurred in 31.5% of cases, and was encountered most frequently in patients who underwent emergency and urgent operations. It was established that concomitant obesity in patients with acute cholecystitis is a factor raising the risk of postoperative pyo-inflammatory complications. The immune status was found to be significantly depressed. Preoperative immunoprophylaxis should be applied to prevent pyo-inflammatory complications after the operation.


Assuntos
Colecistite/complicações , Obesidade/complicações , Doença Aguda , Adulto , Idoso , Colecistectomia , Colecistite/imunologia , Colecistite/cirurgia , Emergências , Feminino , Humanos , Levamisol/uso terapêutico , Masculino , Pessoa de Meia-Idade , Obesidade/imunologia , Complicações Pós-Operatórias/prevenção & controle , Prodigiozan/uso terapêutico
15.
Klin Med (Mosk) ; 69(3): 77-80, 1991 Mar.
Artigo em Russo | MEDLINE | ID: mdl-2067345

RESUMO

Monotherapy with reaferon (alpha 2-interferon) versus prodigiosan plus ibuprofen combination was investigated in acute viral hepatitis B. The drugs were found to stimulate cellular immunity and to induce a decrease of total serum IgE levels. The effect of prodigiosan combined with ibuprofen proved more pronounced.


Assuntos
Hepatite B/terapia , Interferon Tipo I/uso terapêutico , Doença Aguda , Adolescente , Adulto , Idoso , Quimioterapia Combinada , Hepatite B/sangue , Humanos , Ibuprofeno/farmacologia , Ibuprofeno/uso terapêutico , Interferon alfa-2 , Interferon-alfa , Pessoa de Meia-Idade , Prodigiozan/farmacologia , Prodigiozan/uso terapêutico , Proteínas Recombinantes
16.
Klin Khir (1962) ; (5): 3-5, 1991.
Artigo em Russo | MEDLINE | ID: mdl-1875615

RESUMO

The parallel study of the content of large granule-containing lymphocytes (LGL) and natural killer activity (NKA) in donors, patients with benign tumors in the lungs and bronchial or pulmonary cancer in operative intervention and combined cryosurgical treatment was carried out. The stimulating effect of cryodestruction of malignant tumors with their subsequent spontaneous thawing on LGL content and NKA in patients was established. Administration of prodigiosan immunomodulator contributed to increase in natural resistance of an organism of the patients. The positive correlation of NKA and LGL content was noted.


Assuntos
Criocirurgia , Células Matadoras Naturais/imunologia , Neoplasias Pulmonares/imunologia , Linfócitos/imunologia , Neoplasias Brônquicas/imunologia , Neoplasias Brônquicas/cirurgia , Testes Imunológicos de Citotoxicidade , Humanos , Neoplasias Pulmonares/cirurgia , Linfócitos/citologia , Prodigiozan/uso terapêutico
18.
Farmakol Toksikol ; 53(6): 36-9, 1990.
Artigo em Russo | MEDLINE | ID: mdl-1981989

RESUMO

In experiments on white male mice it was found that an immunostimulant prodigiozan suppresses the activity of cytochrome P-450-dependent liver monohygenases that results in modulation of the activity of neuroleptics (aminazine and haloperidol) administered against its background. Their activity is assessed by the "open field "test" and the "tail suspension test". One could observe a delay of the occurrence of the neuroleptics' effect and prolongation of the effect. Acute toxicity of aminazine was shown to decrease. The changes are most probably due to a slowing of metabolism of the neuroleptics in the liver. On the other hand, administration of neuroleptics against the background of prodigiozan fails to affect its immunostimulating effect despite diverse influences of the drugs on the activity of the liver monooxygenase.


Assuntos
Adjuvantes Imunológicos , Prodigiozan/farmacocinética , Psicotrópicos/farmacocinética , Animais , Antipsicóticos/farmacocinética , Antipsicóticos/toxicidade , Comportamento Animal/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Interações Medicamentosas , Imunidade Inata/efeitos dos fármacos , Dose Letal Mediana , Fígado/efeitos dos fármacos , Fígado/enzimologia , Masculino , Camundongos , Prodigiozan/uso terapêutico , Infecções por Pseudomonas/tratamento farmacológico , Infecções por Pseudomonas/mortalidade , Psicotrópicos/toxicidade
19.
Mikrobiol Zh (1978) ; 52(3): 70-6, 1990.
Artigo em Russo | MEDLINE | ID: mdl-2120554

RESUMO

A model of experimental typhus infection has shown that not only specific protection factors but also nonspecific ones are very important to remove Rickettsia prowazekii from macroorganisms. A complex application of antibiotics and drugs increasing immunobiological reactivity of the organism (prodigiosan, methyl uracil) noticeably decreases the rickettsia persistence level in the organism of experimental animals, the indices of specific and nonspecific protection being increased.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Antibacterianos/uso terapêutico , Rickettsia prowazekii/efeitos dos fármacos , Tifo Epidêmico Transmitido por Piolhos/tratamento farmacológico , Animais , Doxiciclina/uso terapêutico , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Cobaias , Prodigiozan/uso terapêutico , Rickettsia prowazekii/isolamento & purificação , Rifampina/uso terapêutico , Tifo Epidêmico Transmitido por Piolhos/imunologia , Tifo Epidêmico Transmitido por Piolhos/microbiologia , Uracila/análogos & derivados , Uracila/uso terapêutico
20.
Artigo em Russo | MEDLINE | ID: mdl-2385993

RESUMO

The influence of prodigiosan, salmosan, polyribonate and levamisole on the body nonspecific and specific resistance to S. typhi strain 4446 has been studied. Prodigiosan and salmosan have proved to be the most effective. The injection of these compounds simultaneously with typhoid vaccine (both chemical adsorbed vaccine and alcohol-treated vaccine, enriched with Vi-antigen) significantly increases the survival rate of immunized animals (by 35-45%), elevates the resistance index (1.5- to 2.3-fold) and the effectiveness index of the vaccine (17- to 32-fold) in comparison with the controls. Besides, prodigiosan and salmosan alone are capable of increasing nonspecific resistance to S. typhi strain 4446, which is manifested by an increase of the survival rate of stimulated animals by 61.87%. Proceeding from the results thus obtained, the possibility of good prospects for prodigiosan and salmosan in the prophylaxis of typhoid fever in humans may be inferred.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Febre Tifoide/prevenção & controle , Animais , Avaliação Pré-Clínica de Medicamentos , Imunidade Inata/efeitos dos fármacos , Imunidade Inata/imunologia , Masculino , Camundongos , Compostos Orgânicos , Polissacarídeos Bacterianos/uso terapêutico , Prodigiozan/uso terapêutico , Salmonella typhi/efeitos dos fármacos , Salmonella typhi/imunologia , Febre Tifoide/imunologia , Febre Tifoide/mortalidade , Vacinas Tíficas-Paratíficas/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...